Association of lifespan reproductive duration with depression in Swedish twins: The role of hormone replacement therapy

Int J Gynaecol Obstet. 2023 Jul;162(1):309-316. doi: 10.1002/ijgo.14676. Epub 2023 Feb 3.

Abstract

Objective: To examine the association between reproductive duration and postmenopausal depression (taking the use of hormone replacement therapy [HRT] into account).

Methods: In this population-based cohort study, 11 320 postmenopausal women (mean age 63.6 years) were followed for up to 18 years. Reproductive duration was categorized into three groups: short (≤34 years), average (35-39 years), and long (≥40 years). Depression was ascertained from the Sweden National Patient Registry.

Results: During the follow up, 593 (5.24%) women developed depression. In the multi-adjusted generalized estimating equation model, the odds ratios (ORs) of depression were 1.28 (95% confidence interval [CI] 1.05-1.55) and 1.25 (95% CI 1.01-1.55) for women with short and long reproductive durations, respectively, compared with those women with average reproductive duration. Women with a non-typical reproductive duration (≤34 or ≥40 years) who received HRT were at a higher risk of depression (OR 1.82, 95% CI 1.42-2.33). There was a significant additive interaction between non-typical reproductive duration and the use of HRT on depression (attributable proportion 0.26, 95% CI 0.03-0.50).

Conclusion: Women with a short or long reproductive duration, especially those with a history of HRT use, have a higher risk of depression after menopause compared with those with an average reproductive duration.

Keywords: depression; hormone replacement therapy; reproductive duration; twin study.

MeSH terms

  • Cohort Studies
  • Depression* / epidemiology
  • Estrogen Replacement Therapy / adverse effects
  • Female
  • Hormone Replacement Therapy / adverse effects
  • Humans
  • Longevity*
  • Male
  • Middle Aged
  • Risk Factors
  • Sweden / epidemiology